Angiogenesis as an independent prognostic indicator in node-negative breast cancer

被引:0
作者
Arora, R
Joshi, K [1 ]
Nijhawan, R
Radotra, BD
Sharma, SC
机构
[1] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Cytol, Chandigarh 160012, India
[3] Postgrad Inst Med Educ & Res, Dept Radiotherapy, Chandigarh 160012, India
来源
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY | 2002年 / 24卷 / 04期
关键词
angiogenesis; pathologic; breast cancer; prognosis;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
OBJECTIVE: To quantitate tumor angiogenesis in carcinoma of the breast (stage T2N0M0) by computerized image analysis of CD-31-stained histologic sections and, keeping in view the heterogeneity of tumors, to assess which areas of neovascularization provide the best prognostic indicator. STUDY DESIGN: Thirty-six cases of infiltrating duct carcinoma of the breast, stage T2N0M0, with follow-up of five years, were analyzed. All cases had received uniform initial treatment in the form of mastectomy with axillary clearance and radiotherapy. Intratumoral microvessel density (IMD) counts were done on "hot spots" and "non-hot spots" on CD-31-stained sections using computerized image analysis. Angiogenesis was correlated with other variables, such as age, menopausal status, histologic grade and proliferative activity by univariate and multivariate analyses. RESULTS: Hot-spot IMD counts were highly significant independent prognostic markers in univariate and multivariate analyses. Background vascularity of a tumor was of no value in prognosticating. CONCLUSION: In patients with node negative breast carcinoma, IMD counts in hot spots are an independent prognostic factor in disease free and overall survival and can be used to separate out patients with T2N0M0 stage in need of systemic adjuvant therapy.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 20 条
[1]  
[Anonymous], 1995, The molecular basis of cancer
[2]  
BARBARESCHI M, 1995, APPL IMMUNOHISTOCHEM, V3, P75
[3]   NOVEL METHODS FOR THE DETERMINATION OF THE ANGIOGENIC ACTIVITY OF HUMAN TUMORS [J].
BARBARESCHI, M ;
GASPARINI, G ;
MORELLI, L ;
FORTI, S ;
DALLAPALMA, P .
BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (02) :181-192
[4]   TUMOR INTERACTIONS WITH THE VASCULATURE - ANGIOGENESIS AND TUMOR-METASTASIS [J].
BLOOD, CH ;
ZETTER, BR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) :89-118
[5]  
CASTELLO P, 1995, HUM PATHOL, V26, P1181
[6]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[7]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[8]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[9]   CLINICAL IMPORTANCE OF THE DETERMINATION OF TUMOR ANGIOGENESIS IN BREAST-CARCINOMA - MUCH MORE THAN A NEW PROGNOSTIC TOOL [J].
GASPARINI, G ;
HARRIS, AL .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :765-782
[10]   Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis [J].
Heimann, R ;
Ferguson, D ;
Gray, S ;
Hellman, S .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :147-158